Board of Directors

Mr. Rahul Guha is the Managing Director, and Chief Executive Officer of the Company and President of Operations at API Group.

He is a graduate of the Indian Institute of Management, Bangalore (IIM-B), and has nearly 17 years of experience at Boston Consulting Group (BCG), where he led the Health Care & Life Sciences practice.

Before joining BCG, Mr. Guha was the Co-founder and CEO of Nautilus Software and served as the Chief Technology Officer (CTO)at ValuePay.com, overseeing product development for the US market. He has extensive experience in MedTech and HealthTech andhas worked closely with multiple startups, supporting their digital incubation. With over two decades of experience in thepharmaceutical sector, he has been an active contributor to its growth and innovation.

Mr. Guha also serves as a Non-Executive Director on the Board of Nueclear Healthcare Limited, a wholly owned subsidiary of the Company.

Mr. Nishant Shah is an Independent Director of the Company.

A Fellow Member of the Institute of Chartered Accountants of India, Mr. Shah has over 12 years of experience primarily in banking andfinancial services. He has held key roles at leading global financial institutions, including Citibank and Standard Chartered. He spent 13years at JPMorgan Chase, where he served in senior leadership positions, including Head of Operating Risk for India.

Recognized as an authority in banking and finance, Mr. Shah has worked extensively with regulators and played a pivotal role inindustry-wide initiatives. Currently, he is the Managing Partner of Jackstien Practices and the CEO of Jonosfero International.

Mr. Shah has been honored with prestigious awards such as the India Award for Excellence and CEO Awards. Passionate aboutintegrating emerging technologies into risk management, he leverages advancements in Web 3.0, Machine Learning, and FinTech toenhance financial and regulatory frameworks. He is a key contributor to policy discussions and has held leadership positions in variousregulatory bodies, industry associations, and self-regulatory organizations.

He also serves as an Independent Director on the Board of Nueclear Healthcare Limited and is a Designated Partner at 9HireInternational LLP, Jonosfero International LLP, and Jackstien Practices and Consulting International LLP.

Mr. Anandh Sundar is an Independent Director of the Company.

He holds a PGDM from IIM Ahmedabad and is a fellow member of the Institute of Chartered Accountants of India, having been a rank holder at all levels. With over 14 years of experience in finance and management, he possesses expertise in corporate finance, strategy, fundraising, project management, risk management, internal audit, and insurance. He has worked with Indian companies, multinational corporations, and foreign entities and currently collaborates closely with startups.

Mr. Sundar also serves as Independent Director on the Boards of Nueclear Healthcare Limited and Cera Sanitaryware Limited.

Dr. Prapti Gilada is an Independent Director of the Company.

She is the CEO and Consultant Microbiologist at UniLabs Diagnostics. Additionally, she serves as a Consultant Microbiologist at Masina Hospital Trust and as the Infection Control Officer at the Head and Neck Cancer Institute of India.

Dr. Gilada holds a postgraduate degree in Microbiology from Seth GS Medical College and KEM Hospital. She has also completed a Fellowship in HIV and Drug-Resistant TB from UNAIDS’ CAPRISA (Centre for the AIDS Program of Research in South Africa) in Durban, South Africa.

She previously worked as:

• Consultant Microbiologist and Infection Control Officer at Prince Aly Khan Hospital (2018–2021), where she led the hospital’s COVID-19 infection control team.
• Consultant Microbiologist at Picture This by Jankharia (2018–2020).
• Consultant Microbiologist at the Group of TB Hospitals, Sewri (2016–2018), Asia’s largest TB hospital.

Dr. Gilada also serves as a Director on the Boards of Nueclear Healthcare Limited and Unison Medicare and Research Centre Private Limited.

Dr. Harshil Vora is an Independent Director of the Company.

He is a highly qualified and experienced Consultant Orthopaedic & Specialty Knee Surgeon. He holds an MBBS degree and has completed an MS in Orthopaedics. Additionally, he has undergone super-specialty training in England, where he pursued an MCh (Hip & Knee). Currently, he practices at Dr. Vora’s Orthopaedic Centre, Mumbai.

Dr. Vora has 13 years of clinical orthopaedic experience, including three years of international experience. He has worked at globally renowned centers of excellence, such as NYU Langone Medical Center, Birmingham Heartlands Hospital, Wrightington Hospital, and Cambridge University Hospital.

His professional achievements include Advanced Trauma Life Support (ATLS) certification and a gold medal from the Orthopaedic Department at Bharati Hospital, Pune. He has also received outstanding letters of recommendation from esteemed professionals in the field. Actively involved in research, he has authored scholarly articles and presented papers and posters at national and international conferences.

Dr. Vora’s expertise lies in soft tissue knee procedures and reconstructive surgeries, particularly total knee replacements.

Dr. Indumati Gopinathan is an Independent Director on the Board of the Company.

She is a postgraduate (M.D.) in Pathology and a highly reputed pathologist with ocular pathology as an area of special interest and recognized as a leading commentator on Telepathology. In addition to her medical expertise, she is a healthcare columnist for The Times of India and Healthcare Express, a leading weekly healthcare publication by the Indian Express group and is Wikipedia profiled. She has numerous peer reviewed publications to her credit.

Dr. Gopinathan is a committee member of Practising Pathologists of India and chief editor of its newsletter.

Dr Gopinathan has served as past president and Hon secretary of Indian medical Association, Chembur, 

A past Rotary club president and reviewer of Rotary global grant funded projects in Rotary, she has actively participated in numerous vocational training teams and community service programs globally through Rotary.

Mr. Dharmil Sheth is a Non-Executive and Non-Independent Director of the Company.

He holds a bachelor’s degree in electronics engineering from K.J. Somaiya College of Engineering, University of Mumbai, and a postgraduate diploma in management (marketing) from the Institute of Management Technology, Ghaziabad.

Mr. Sheth began his career with MakeMyTrip (India) Private Limited, where he was part of the online products team. He later co-founded 91Streets Media Technologies Private Limited, which subsequently merged with API Holdings Limited. He is also a Co-founder of API Holdings Limited.

He serves as a Director on the Boards of:

• Emergent Bharat Finance Private Limited
• All Home Bharat Platform Private Limited
• Digi Bharat Platform Ventures Private Limited
• 91Streets Media Technologies Private Limited
• Nueclear Healthcare Limited
• Solar Magic Private Limited

Additionally, he is a Designated Partner at:

• Hadd Consultancy Services LLP
• D Three S Consultancy Services LLP

Mr. Hardik Dedhia is a Non-Executive and Non-Independent Director of the Company.

He holds a bachelor’s degree in electronics and telecommunication engineering from the University of Mumbai, Maharashtra, and a master’s degree in electrical and computer engineering from Carnegie Mellon University, Pennsylvania.

Mr. Dedhia began his career as a Quality Assurance Engineer at NetApp. He later served as the Chief Technical Officer of Ascent Health and Wellness Solutions Private Limited, which subsequently merged with API Holdings Limited. He is also a Co-founder and Whole-time Director of API Holdings Limited.

He serves as a Director on the Boards of:

• Emergent Bharat Finance Private Limited
• Digi Bharat Platform Ventures Private Limited
• Lok Prakash Vidhya Private Limited
• Aahaan Commercials Private Limited
• Nueclear Healthcare Limited
• My Pos Technologies Private Limited
• Docon Technologies Private Limited

Dr. Dhaval Shah is a Non-Executive and Non-Independent Director of the Company.

He holds a postgraduate diploma in management from XLRI, Xavier School of Management, Jamshedpur, and an MBBS degree from Maharashtra University of Health Sciences, Nasik.

Dr. Shah began his career as a Consultant at McKinsey & Company Inc. He later co-founded 91Streets Media Technologies Private Limited, which subsequently merged with API Holdings Limited. He is also a Co-founder and Whole-time Director of API Holdings Limited.

He serves as a Director on the Boards of:

• Emergent Bharat Finance Private Limited
• All Home Bharat Platform Private Limited
• Digi Bharat Platform Ventures Private Limited
• API Holdings Limited
• DRS Shah Advisors Private Limited
• Docon Technologies Private Limited
• 91Streets Media Technologies Private Limited
• Nueclear Healthcare Limited

Additionally, he is a Designated Partner at:

• D Threes Consultancy Services LLP
• Hadd Consultancy Services LLP